Wen Xu

2.9k total citations · 3 hit papers
37 papers, 2.1k citations indexed

About

Wen Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wen Xu has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Wen Xu's work include Liver physiology and pathology (4 papers), Cancer Cells and Metastasis (4 papers) and Inflammasome and immune disorders (4 papers). Wen Xu is often cited by papers focused on Liver physiology and pathology (4 papers), Cancer Cells and Metastasis (4 papers) and Inflammasome and immune disorders (4 papers). Wen Xu collaborates with scholars based in China, Poland and United States. Wen Xu's co-authors include Yi Huang, Rongbin Zhou, Zhengfeng Yin, Lu Cao, Haihua Qian, Jian Liao, Yu Zhang, Yanming Zhou, Mengchao Wu and Ruixiu Zhang and has published in prestigious journals such as Cancer Research, Brain Research and Clinical Cancer Research.

In The Last Decade

Wen Xu

36 papers receiving 2.1k citations

Hit Papers

NLRP3 inflammasome activation and cell death 2021 2026 2022 2024 2021 2024 2025 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Xu China 18 1.2k 375 339 326 233 37 2.1k
Xiaofeng Wu China 24 899 0.8× 456 1.2× 339 1.0× 430 1.3× 231 1.0× 105 2.0k
Xiuyan Yang China 29 970 0.8× 302 0.8× 471 1.4× 324 1.0× 161 0.7× 133 2.7k
Qian Chen China 25 928 0.8× 161 0.4× 377 1.1× 342 1.0× 187 0.8× 75 2.1k
Songqing He China 30 1.2k 1.0× 378 1.0× 333 1.0× 622 1.9× 212 0.9× 108 2.4k
Shizhong Bu China 30 1.5k 1.3× 298 0.8× 197 0.6× 626 1.9× 250 1.1× 86 2.6k
Angela Raucci Italy 25 1.2k 1.0× 244 0.7× 804 2.4× 381 1.2× 252 1.1× 43 3.1k
Fei Yang China 25 1.0k 0.9× 248 0.7× 467 1.4× 344 1.1× 102 0.4× 93 2.0k
Bahjat Al‐Ani Saudi Arabia 30 816 0.7× 166 0.4× 646 1.9× 498 1.5× 222 1.0× 94 3.4k
Weiliang Xia China 32 1.4k 1.2× 407 1.1× 217 0.6× 486 1.5× 257 1.1× 103 2.8k
Rui Ding China 30 1.3k 1.2× 388 1.0× 396 1.2× 256 0.8× 128 0.5× 92 2.5k

Countries citing papers authored by Wen Xu

Since Specialization
Citations

This map shows the geographic impact of Wen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Xu more than expected).

Fields of papers citing papers by Wen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Xu. The network helps show where Wen Xu may publish in the future.

Co-authorship network of co-authors of Wen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Xu. A scholar is included among the top collaborators of Wen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Xu. Wen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Wen, Yi Huang, & Rongbin Zhou. (2025). NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cellular and Molecular Immunology. 22(4). 341–355. 49 indexed citations breakdown →
2.
Tan, Rong, Meishan Liu, Wen Xu, et al.. (2025). Digital cognitive behavioral therapy as a novel treatment for insomnia. World Journal of Psychiatry. 15(4). 104042–104042.
3.
Ru, Yi, Ying‐Li Luo, Xianyu Luo, et al.. (2024). Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases. Science Advances. 10(13). eadk1200–eadk1200. 80 indexed citations breakdown →
4.
Huang, Yi, Yun Guo, Yan Zhou, et al.. (2023). Tivantinib alleviates inflammatory diseases by directly targeting NLRP3. iScience. 26(3). 106062–106062. 10 indexed citations
5.
Chen, Yan, Yue Zhang, Jiayi Lu, et al.. (2022). Characteristics of Prognostic Programmed Cell Death–Related Long Noncoding RNAs Associated With Immune Infiltration and Therapeutic Responses to Colon Cancer. Frontiers in Immunology. 13. 828243–828243. 7 indexed citations
6.
Xu, Wen & Yi Huang. (2022). Regulation of Inflammatory Cell Death by Phosphorylation. Frontiers in Immunology. 13. 851169–851169. 26 indexed citations
7.
Wang, Xuncui, Feng Gao, Wen Xu, et al.. (2021). Depichering the Effects of Astragaloside IV on AD‐Like Phenotypes: A Systematic and Experimental Investigation. Oxidative Medicine and Cellular Longevity. 2021(1). 1020614–1020614. 25 indexed citations
8.
Huang, Yi, Wen Xu, & Rongbin Zhou. (2021). NLRP3 inflammasome activation and cell death. Cellular and Molecular Immunology. 18(9). 2114–2127. 993 indexed citations breakdown →
10.
Song, Zhujin, Hui Chen, Wen Xu, Sheng-Bing Wu, & Guoqi Zhu. (2018). Basolateral amygdala calpain is required for extinction of contextual fear-memory. Neurobiology of Learning and Memory. 155. 180–188. 21 indexed citations
11.
Xu, Wen, et al.. (2018). GPR30 activation improves memory and facilitates DHPG-induced LTD in the hippocampal CA3 of middle-aged mice. Neurobiology of Learning and Memory. 149. 10–19. 32 indexed citations
12.
Zhang, Yu, Jun Li, Lu Cao, Wen Xu, & Zhengfeng Yin. (2012). Circulating Tumor Cells in Hepatocellular Carcinoma: Detection Techniques, Clinical Implications, and Future Perspectives. Seminars in Oncology. 39(4). 449–460. 57 indexed citations
13.
Liao, Jian, Ruixiu Zhang, Haihua Qian, et al.. (2012). Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 420(2). 308–314. 8 indexed citations
14.
Xu, Wen, Lu Cao, Lei Chen, et al.. (2011). Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy. Clinical Cancer Research. 17(11). 3783–3793. 128 indexed citations
15.
Qian, Hui, et al.. (2011). [Inhibition of culture supernatant of mesenchymal stem cells on macrophages RAW264.7 activated by soluble egg antigen of Schistosoma japonicum].. PubMed. 29(6). 425–30. 4 indexed citations
16.
Zhou, Yanming, Jiamei Yang, Bin Li, et al.. (2010). Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.. PubMed. 9(1). 33–7. 63 indexed citations
17.
Kane, John M., Olawale Osuntokun, Ludmila Kryzhanovskaya, et al.. (2009). A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia. The Journal of Clinical Psychiatry. 70(4). 572–581. 54 indexed citations
18.
Mao, Fei, Wen Xu, Hui Qian, et al.. (2009). [The expression of Toll-like receptor 8 and cytokines in rheumatoid arthritis mice induced by chicken II collogen].. PubMed. 25(4). 312–4, 318. 1 indexed citations
19.
Mao, Fei, et al.. (2009). Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflammation Research. 59(3). 219–225. 77 indexed citations
20.
Gao, Shan, Wen Xu, & Ying Wan. (1996). [Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential].. PubMed. 18(4). 250–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026